Global Assets Advisory’s Novo Nordisk NVO Stock Holding History

Global Assets Advisory’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-381	Closed	-$48.6K	–	363
2024 Q1	$48.6K	Buy	+381	New	+$45.4K	0.03%	283

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Global Assets Advisory's NVO Position: Q2 2024 in Review

Global Assets Advisory sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 381 shares — an estimated $48.6K sold.

Global Assets Advisory first reported a position in NVO in Q1 2024 and held it in 1 quarter. The position peaked at $48.6K in Q1 2024. 1,865 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

Global Assets Advisory reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
Global Assets Advisory sold 381 Novo Nordisk shares in Q2 2024, an estimated $48.6K.
Global Assets Advisory first reported a position in Novo Nordisk in Q1 2024 and held it in 1 quarter.
Global Assets Advisory's Novo Nordisk position peaked at $48.6K in Q1 2024.
1,865 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Global Assets Advisory's 13F filing for Q2 2024, filed 30 Jul 2024.